Roivant Sciences Ltd (FRA:87S)
€ 10.975 -1.02 (-8.5%) Market Cap: 8.34 Bil Enterprise Value: 3.28 Bil PE Ratio: 2.16 PB Ratio: 1.74 GF Score: 60/100

Q2 2023 Roivant Sciences Ltd Earnings Call Transcript

Nov 14, 2022 / 01:00PM GMT
Release Date Price: €4.77 (-1.14%)
Operator

Good day, and thank you for standing by. Welcome to the Roivant 2Q 2022 Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Jeffrey Kalmus, Head of Strategic Finance. Please go ahead.

Jeffrey Kalmus

Good morning, and thank you for joining today's call to discuss Roivant's financial results for the quarter ended September 30, 2022. Presenting today, we have Matt Gline, our Chief Executive Officer. For those dialing in via conference call, you can find the slides being presented today as well as the press release announcing these updates on our IR website at www.investor.roivant.com. We'll also be providing the current slide numbers as we present to help you follow along.

I would like to remind you that we will be making certain forward-looking statements during today's presentation that reflect our current views and expectations, including those related to our financial performance and the potential entities of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot